08.12.2012 Views

Interventions for Tuberculosis Control and Elimination 2002

Interventions for Tuberculosis Control and Elimination 2002

Interventions for Tuberculosis Control and Elimination 2002

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

680. Lange L. Zu den Tuberkuloseschutzimpfungen in Lübeck. Zeitschr Tuberkulose<br />

1930; 57: 305-10.<br />

681. Schürmann P, Kleinschmidt H. Pathologie und Klinik der Lübecker<br />

Säuglingstuberkuloseerkrankungen. Arbeiten a d Reichsges-Amt 1935; 69: 25-204.<br />

682. Lange L, Pescator H. Bakteriologische Untersuchungen zur Lübecker<br />

Säuglingstuberkulose. Arbeiten a d Reichsges-Amt 1935; 69: 205-305.<br />

683. Hashimoto T. The vaccination, theory <strong>and</strong> practice. BCG. Tokyo: International<br />

Medical Foundation Japan, 1975.<br />

684. Gheorghiu M, Augier J, Lagrange PH. Maintenance <strong>and</strong> control of the French<br />

BCG strain 1173-P2 (primary <strong>and</strong> secondary seed-lots).<br />

81: 281-8.<br />

Bull Inst Pasteur 1983;<br />

685. Behr MA, Small PM. A historical <strong>and</strong> molecular phylogeny of BCG strains.<br />

Vaccine 1999; 17: 915-22.<br />

686. Oettinger T, Jørgensen M, Ladefoged A, Hasløv K, Andersen P. Development<br />

of the Mycobacterium bovis BCG vaccine: review of the historical <strong>and</strong> biochemical<br />

evidence <strong>for</strong> a genealogical tree. Tubercle Lung Dis 1999; 79: 243-50.<br />

687. Behr MA, Schroeder BG, Brinkman JB, Slayden RA, Barry CE, III. A point<br />

mutation in the mma3 gene is responsible <strong>for</strong> impaired methoxymycolic acid production<br />

in Mycobacterium bovis BCG strains obtained after 1927.<br />

2000; 182: 3394-9.<br />

J Bacteriol<br />

688. Lotte A, Wasz-Höckert O, Poisson N, Dumitrescu N, Verron M, Couvet E. BCG<br />

complications. Estimates of the risks among vaccinated subjects <strong>and</strong> statistical<br />

analysis of their main characteristics. Adv Tuberc Res 1984; 21: 107-93.<br />

689. Lotte A, Wasz-Höckert O, Poisson N, Dumitrescu N, Verron M, Couvet E. A<br />

bibliography of the complications of BCG vaccination. A comprehensive list of<br />

the World Literature since the introduction of BCG up to July 1982, supplemented<br />

by over 100 personal communications. Adv Tuberc Res 1984; 21: 194-245.<br />

690. FitzGerald JM. Management of adverse reactions to Bacille Calmette-Guérin<br />

vaccine. Clin Infect Dis 2000; 31(suppl): S75-S76.<br />

691. Lotte A, Wasz-Höckert O, Poisson N, Engbaek H, L<strong>and</strong>mann H, Quast U,<br />

Andrasofszky B, Lugosi L, Vadasz I, Mihailescu P, Sudic D, Pal D. Second<br />

IUATLD study on complications induced by intradermal BCG-vaccination.<br />

Int Union Tuberc Lung Dis 1988; 63(2): 47-59.<br />

Bull<br />

692. Böttiger M, Romanus V, De Verdier C, Boman G. Osteitis <strong>and</strong> other complications<br />

caused by generalized BCG-itis.<br />

Sc<strong>and</strong> 1982; 71: 471-8.<br />

Experiences in Sweden. Acta Paediatr<br />

693. Schopfer K, Matter L, Brunner C, Pagon S, Stanisic M, Baerlocher K. BCG<br />

osteomyelitis. Case report <strong>and</strong> review. Helv Paediat Acta 1982; 37: 73-81.<br />

694. Kröger L, Korppi M, Br<strong>and</strong>er E, Kröger H, Wasz-Höckert O, Bacman A, Rapola J,<br />

Launiala K, Katila ML. Osteitis caused by Bacille Calmette-Guérin vaccination:<br />

a retrospective analysis of 222 cases. J Infect Dis 1995; 172: 574-6.<br />

215

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!